Short Interest in ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Rises By 305.8%

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) was the target of a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 41,800 shares, a growth of 305.8% from the December 15th total of 10,300 shares. Based on an average trading volume of 12,800 shares, the days-to-cover ratio is presently 3.3 days.

ProShares UltraShort Nasdaq Biotechnology Price Performance

Shares of ProShares UltraShort Nasdaq Biotechnology stock traded down $0.05 during trading hours on Tuesday, reaching $18.34. The company had a trading volume of 4,834 shares, compared to its average volume of 5,733. ProShares UltraShort Nasdaq Biotechnology has a one year low of $14.05 and a one year high of $21.10. The business has a fifty day simple moving average of $16.88 and a 200 day simple moving average of $15.81.

ProShares UltraShort Nasdaq Biotechnology Increases Dividend

The firm also recently declared a dividend, which was paid on Tuesday, December 31st. Shareholders of record on Monday, December 23rd were paid a dividend of $0.2064 per share. The ex-dividend date was Monday, December 23rd. This is an increase from ProShares UltraShort Nasdaq Biotechnology’s previous dividend of $0.15.

Institutional Trading of ProShares UltraShort Nasdaq Biotechnology

An institutional investor recently bought a new position in ProShares UltraShort Nasdaq Biotechnology stock. Jane Street Group LLC bought a new stake in shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 10,520 shares of the company’s stock, valued at approximately $158,000. Jane Street Group LLC owned approximately 4.78% of ProShares UltraShort Nasdaq Biotechnology at the end of the most recent quarter.

ProShares UltraShort Nasdaq Biotechnology Company Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.